If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1
The safety and effectiveness of Baqsimi have not been established in pediatric patients younger than 4 years of age.1
Enclosed Prescribing Information
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019